GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Star Lake Bioscience Co Inc (SHSE:600866) » Definitions » EV-to-FCF

Star Lake Bioscience Co (SHSE:600866) EV-to-FCF : 5.88 (As of May. 01, 2024)


View and export this data going back to 1994. Start your Free Trial

What is Star Lake Bioscience Co EV-to-FCF?

EV-to-FCF is calculated as enterprise value divided by its free cash flow. As of today, Star Lake Bioscience Co's Enterprise Value is ¥12,645 Mil. Star Lake Bioscience Co's Free Cash Flow for the trailing twelve months (TTM) ended in Mar. 2024 was ¥2,150 Mil. Therefore, Star Lake Bioscience Co's EV-to-FCF for today is 5.88.

The historical rank and industry rank for Star Lake Bioscience Co's EV-to-FCF or its related term are showing as below:

SHSE:600866' s EV-to-FCF Range Over the Past 10 Years
Min: -528.41   Med: -21.43   Max: 4366.76
Current: 5.4

During the past 13 years, the highest EV-to-FCF of Star Lake Bioscience Co was 4366.76. The lowest was -528.41. And the median was -21.43.

SHSE:600866's EV-to-FCF is ranked worse than
51.65% of 393 companies
in the Biotechnology industry
Industry Median: 4.47 vs SHSE:600866: 5.40

EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

As of today (2024-05-01), Star Lake Bioscience Co's stock price is ¥5.66. Star Lake Bioscience Co's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2024 was ¥0.486. Therefore, Star Lake Bioscience Co's PE Ratio for today is 11.65.


Star Lake Bioscience Co EV-to-FCF Historical Data

The historical data trend for Star Lake Bioscience Co's EV-to-FCF can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Star Lake Bioscience Co EV-to-FCF Chart

Star Lake Bioscience Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
EV-to-FCF
Get a 7-Day Free Trial Premium Member Only Premium Member Only 60.46 -96.62 -59.84 10.75 6.44

Star Lake Bioscience Co Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
EV-to-FCF Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 31.67 9.63 9.44 6.44 4.89

Competitive Comparison of Star Lake Bioscience Co's EV-to-FCF

For the Biotechnology subindustry, Star Lake Bioscience Co's EV-to-FCF, along with its competitors' market caps and EV-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Star Lake Bioscience Co's EV-to-FCF Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Star Lake Bioscience Co's EV-to-FCF distribution charts can be found below:

* The bar in red indicates where Star Lake Bioscience Co's EV-to-FCF falls into.



Star Lake Bioscience Co EV-to-FCF Calculation

Star Lake Bioscience Co's EV-to-FCF for today is calculated as:

EV-to-FCF=Enterprise Value (Today)/Free Cash Flow (TTM)
=12645.176/2149.582
=5.88

Star Lake Bioscience Co's current Enterprise Value is ¥12,645 Mil.
Star Lake Bioscience Co's Free Cash Flow for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥2,150 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Star Lake Bioscience Co  (SHSE:600866) EV-to-FCF Explanation

EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

Star Lake Bioscience Co's PE Ratio for today is calculated as:

PE Ratio=Share Price (Today)/Earnings per Share (Diluted) (TTM)
=5.66/0.486
=11.65

Star Lake Bioscience Co's share price for today is ¥5.66.
Star Lake Bioscience Co's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥0.486.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Free Cash Flow is an important financial metric because it represents the actual amount of cash at a company's disposal. Companies with a low EV-to-FCF ratio, combined with a strong balance sheet are generally considered as undervalued.


Star Lake Bioscience Co EV-to-FCF Related Terms

Thank you for viewing the detailed overview of Star Lake Bioscience Co's EV-to-FCF provided by GuruFocus.com. Please click on the following links to see related term pages.


Star Lake Bioscience Co (SHSE:600866) Business Description

Traded in Other Exchanges
N/A
Address
No. 67 Gongnong North Road, Guangdong Province, Zhaoqing, CHN, 526060
Star Lake Bioscience Co Inc is a China-based Pharmaceutical manufacturer. The company is mainly engaged in the research, development, production, and sales of chemical raw materials and pharmaceutical intermediates. Products offered by the company include proline, guanosine, adenosine, adenine, adefovir dipivoxil, memantine hydrochloride, Proline, threonine, lysine, among others. Its products are used in food processing, feed processing, and pharmaceutical manufacturing. Star Lake sells its products through direct sales and distributors in China and overseas markets.

Star Lake Bioscience Co (SHSE:600866) Headlines

No Headlines